This webinar recording features a presentation by Avacta Life Sciences' Chief Technology Officer Dr Matt Johnson. In it, he discusses Affimer® technology, a novel antibody mimetic and powerful antibody alternative. Plus:
Enter your details to access the webinar.
"Using Affimer technology we have been able to demonstrate effective label free electrochemical immunoassays. The performance has exceeded that associated with comparable antibodies”